Perrigo Company plc Sued for Securities Law Violations

LOS ANGELES, Jan. 19, 2026 – Perrigo Company plc (NYSE: PRGO), a globally recognized manufacturer of over-the-counter healthcare products, has been named as a defendant in a class action lawsuit alleging serious violations of U.S. federal securities laws. The lawsuit targets the company’s public statements and disclosures during a defined class period, asserting they were materially false and misleading. Investors who purchased Perrigo shares during that period are encouraged to speak with attorneys to understand their rights and the options available to them.

Overview of the Lawsuit

The action centers on alleged violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 issued by the U.S. Securities and Exchange Commission (SEC). These provisions are designed to protect investors from fraud, deception, and misrepresentation in connection with the purchase or sale of securities.

According to the complaint, Perrigo made public statements that misrepresented critical information about its business operations, notably following its acquisition of Nestlé’s baby formula business. Investors claim Perrigo’s disclosures failed to accurately describe operational and financial conditions, resulting in investment losses for shareholders.

Allegations of Misleading Statements

The lawsuit alleges that during the class period running from February 27, 2025, to November 4, 2025, Perrigo made statements that were materially misleading. Plaintiffs argue that the company significantly under-reported the resources needed to address maintenance issues and operational deficiencies at the newly acquired Nestlé baby formula facilities. As a result, Perrigo reportedly faced unexpectedly high capital expenditures that negatively affected financial performance and shareholder value.

These claims are consistent with similar investor alerts and actions from other law firms, which highlight alleged misrepresentations related to Perrigo’s financial disclosures and operational challenges.

Who Is Eligible to Join the Class Action?

The class includes all persons and entities who purchased or otherwise acquired Perrigo Company plc common stock during the class period — from February 27, 2025, through November 4, 2025 — and suffered financial losses as a result of the alleged misconduct. Shareholders who fall within this time frame may have the right to participate in the lawsuit and seek compensation for their losses.

Importantly, investors do not need to serve as the lead plaintiff in order to participate in any settlement or recovery. However, there is a limited window for class members to take certain legal steps if they wish to be considered for appointment as lead plaintiff.

Lead Plaintiff Deadline

The deadline for potential lead plaintiffs to file a motion with the court is January 16, 2026. Missing this deadline could affect a shareholder’s ability to have a voice in key aspects of the litigation, including discovery and settlement negotiations.

Various law firms involved in investor representation have also issued reminders about this deadline, reflecting its importance for participating shareholders.

Background: Perrigo and Investor Concerns

Perrigo Company plc is a leading global manufacturer of over-the-counter healthcare products, including nutritional and wellness items. The company’s strategic acquisitions, like that of Nestlé’s baby formula business, are aimed at expanding its product offerings and market reach. However, integration challenges and unexpected financial burdens linked to such acquisitions have prompted investor scrutiny and legal action.

Allegations that Perrigo’s public disclosures overstated the company’s prospects and understated financial risks are at the heart of the complaint. If proven, these claims could establish that Perrigo misled investors about its operational performance and long-term outlook.

Class Action and Securities Law Explained

A class action lawsuit allows a group of investors with similar claims to sue on behalf of all affected parties. In securities cases, plaintiffs typically allege that material misstatements or omissions in public disclosures caused financial harm by inflating stock prices or concealing risks. If the court finds in favor of the plaintiffs, affected investors may recover damages.

Such lawsuits are critical mechanisms to ensure companies provide accurate and transparent information to the investing public, fostering trust and integrity in financial markets.

What Investors Should Do Next

Investors who purchased Perrigo shares during the class period and experienced losses should consider reaching out to experienced securities litigation attorneys. Law firms representing investors can assess individual cases, explain legal rights, and guide shareholders on how to join the lawsuit or pursue lead plaintiff status.

Participation in class action litigation does not typically require upfront legal fees; most firms work on a contingency basis, meaning they are paid only if investors recover damages.

Key Steps for Investors

• Review your trading records to confirm whether you purchased PRGO shares during the class period.
• Contact a qualified securities law firm to discuss your potential claim.
• Ensure that any lead plaintiff motion is filed by the January 16, 2026 deadline if seeking a leadership role in the lawsuit.
• Monitor updates in the litigation for new developments and potential settlements.

Conclusion

The class action lawsuit against Perrigo Company plc underscores the importance of transparent corporate disclosures and the legal protections available to investors under U.S. securities laws. Shareholders who believe they were harmed by alleged misrepresentations during the class period have opportunities to seek compensation, but time-sensitive actions may be required to preserve their rights.

#PerrigoLawsuit #PRGO #SecuritiesFraud #InvestorRights #SlimScan #GrowthStocks #CANSLIM